Abstract
The present study describes the synthesis and in vitro anticancer activity of novel piritrexim analogs against human breast cancer cell line MCF-7 and a normal Vero monkey cell line. The scheme involves the formation of 3-(4-nitrophenyl)-4-phenyl-1,8-naphthyridin-2-amine accomplished by the condensation reaction of 4-nitrophenyl acetonitrile, aromatic aldehyde, and 2-aminopyridine using acetic acid as a catalyst. The selected synthesized compounds have been screened against a human breast cancer cell line MCF-7 and a normal Vero monkey cell line, out of which the compounds 4b, 4e, 4f exhibited higher potency (GI50 [<10 µg/mL)], and compounds 4a, 4c show moderate to good activity (GI50 41.4 and 12.4 µg/mL) towards human breast cancer cell line MCF-7. Docking study on dihydrofolate reductase enzyme receptor (DHFR) and epidermal growth factor receptor reveals that compounds 4a, 4b, 4c, and 4e show moderate to good binding along with acceptable glide scores.
Graphical Abstract
Similar content being viewed by others
References
E.M. Grivsky, S. Lee, C.W. Sigel, D.S. Duch, C.A. Nichol, J. Med. Chem. 23, 327–329 (1980)
D.S. Duch, M.P. Edelstein, S.W. Bowers, C.A. Nichol, Cancer Res. 42, 3987–3994 (1982)
W. Uen, A.T. Huang, R. Mennel, S.E. Jones, M.B. Spaulding, K. Killion, K. Havlin, P. Keegan, N.J. Clendeninn, Cancer 69, 1008–1011 (1992)
G.A. Fischer, Biochem. Pharmacol. 11, 1233–1234 (1962)
M. Khorsand, J. Lange, L. Feun, N.J. Clendeninn, M. Collier, G. Wilding, Invest. New Drugs 15, 157–163 (1997)
L.G. Feun, R. Gonzales, N. Savaraj, J. Hanlon, M. Collier, W.A. Robinson, N.J. Clendeninn, J. Clin. Oncol. 9, 464–467 (1991)
E.E. Vokes, I.W. Dimery, C.D. Jacobs, D. Karp, A. Molina, M.A. Collier, M.L. Eble, N.J. Clendeninn, Cancer 67, 2253–2257 (1991)
J.D. Schiesel, M. Carabasi, G. Magill, E. Casper, E. Cheng, L. Marks, J. Feyzi, N.J. Clendeninn, R. Smalley, Invest. New Drugs 10, 97–98 (1992)
R. de Wit, S.B. Kaye, J.T. Roberts, G. Stoter, J. Scott, J. Verweij, Brit. J. Cancer 67, 388–390 (1993)
E.M. Berman, L.M. Werbel, J. Med. Chem. 34, 479–485 (1991)
P. Alberto, R. Peytremann, R. Medenica, M. Beretta-Picolli, Cancer Chemother. Pharmacol. 1, 101–105 (1978)
E.G. de Vries, J.A. Gietema, P. Workman, J.E. Scott, A. Crawshaw, H.T. Dobbs, N.Mulder Dennis, D. Sleijfer, P.H. Willemse, Brit. J. Cancer 68, 641–644 (1993)
C. Sessa, J. de Jong, M. D’Incalci, S. Hatty, O. Pagani, F. Cavalli, Clin. Cancer Res. 2, 1123 (1996)
P.C. Adamson, F.M. Balis, J. Miser, R.J. Wells, W.A. Bleyer, T.E. Williams, A. Gillespie, J.S. Penta, N.J. Clendeninn, D.G. Poplack, Cancer Res. 50, 4464–4467 (1990)
J.B. Smaill, H.D. Hollis Showalter, H. Zhou, A.J. Bridges, D.J. McNamara, D.W. Fry, J.M. Nelson, V. Sherwood, P.W. Vincent, B.J. Roberts, W.L. Elliott, W.A. Denny, J. Med. Chem. 44, 429–440 (2001)
J. Wu, W. Chen, G. Xia, J. Zhang, J. Shao, B. Tan, C. Zhang, W. Yu, Q. Weng, H. Liu, M. Hu, H. Deng, Y. Hao, J. Shen, Y. Yu, ACS Med. Chem. Lett. 4, 974–978 (2013)
M.A. Olayioye, R.M. Neve, H.A. Lane, N.E. Hynes, EMBO J. 19, 3159–3167 (2000)
D.B. Ramachary, M.S. Prasad, Tetrahedron Lett. 51, 5246–5251 (2010)
Y. Higuchi, K. Furukawa, T. Miyazawa, N. Minakawa, Bioconjugate Chem. 25, 1360–1369 (2014)
R. Tangali, R. Naik, H.S.B. Naik, Mol. Divers 12, 139–142 (2008)
T.J. Murray, S.C. Zimmerman, S.V. Kolutuchin, Tetrahedron 51, 635–648 (1995)
G.A. Gross, H. Wuziger, A. Shober, J. Comb. Chem. 8, 153–155 (2006)
A.C. Krueger, D.L. Madigan, D.W. Beno, D.A. Betebenner, R. Carrick, B.E. Green, W. He, D. Liu, C.J. Maring, K. McDaniel, H. Mo, A. Molla, C.E. Motter, T.J. Pilot-Matias, M.D. Tufano, D.J. Kemp, Bioorg. Med. Chem. Lett. 22, 2212–2215 (2012)
Y. Nomura, S. Kashiwagi, K. Sato, A. Matsuda, Angew. Chem. Int. Ed. 53, 12844–12848 (2014)
T.V. Magee et al., J. Med. Chem. 52, 7446–7457 (2009)
W.H. Miller et al., Bioorg. Med. Chem. Lett. 13, 1483–1486 (2003)
W. Engen, T.E. O’Brien, B. Kelly, J. Do, L. Rillera, L.K. Stapleton, J.F. Youngren, M.O. Anderson, Bioorg. Med. Chem. 18, 5995–6005 (2010)
B. Vinod, P. Manoj Kumar, V. Prashanth, I. Baskar, Internet J. Pharmacol. 7, 1 (2008)
H. Ban, M. Muraoka, N. Ohashi, Tetrahedron Lett. 44, 6021–6023 (2003)
R. Siddiqui, P. Rahila, A. Srivastava, A. Srivastava, A. Srivastava, New J. Chem. 37, 3798–3804 (2013)
A.A. Patravale, A.H. Gore, D.R. Patil, G.B. Kolekar, M.B. Deshmukh, P.V. Anbhule, Ind. Eng. Chem. Res. 53, 16568–16578 (2014)
S.S. Undare, N.J. Valekar, A.A. Patravale, D.K. Jamale, S.S. Vibhute, L.S. Walekar, G.B. Kolekar, M.B. Deshmukh, P.V. Anbhule, Res. Chem. Intermed. 42, 4373–4386 (2016)
P.P. Warekar, P.T. Patil, K.T. Patil, D.K. Jamale, G.B. Kolekar, P.V. Anbhule, Synth. Commun. 46, 2022–2030 (2016)
P.P. Warekar, P.T. Patil, K.T. Patil, D.K. Jamale, G.B. Kolekar, P.V. Anbhule, Res. Chem. Intermed. 43, 4115–4127 (2017)
D.C.M. Chan, H. Fu, R.A. Forsch, S.F. Queener, A. Rosowsky, J. Med. Chem. 48, 4420–4431 (2005)
V. Srivastava, A. Kumar, B.N. Mishra, M.I. Siddiqi, Bioinformation 3, 180 (2008)
H. Ogiso, R. Ishitani, O. Nureki, S. Fukai, M. Yamanaka, J.H. Kim, K. Saito, A. Sakamoto, M. Inoue, M. Shirouzu, S. Yokoyama, Cell 110, 775 (2002)
L.C. Groenen, E.C. Nice, A.W. Burgess, Growth Factors 11, 235 (1994)
W. Voigt, Sulforhodamine B assay and chemosensitivity. Methods Mol. Med. 110, 39–48 (2005)
S. Tabassum, R.A. Khan, F. Arjmand, A.S. Juvekar, S.M. Zingde, Eur. J. Med. Chem. 45, 4797–4806 (2010)
A. Gangjee, W. Li, R.L. Kisliuk, V. Cody, J. Pace, J. Piraino, J. Makin, J. Med. Chem. 52, 4892 (2009)
G. Xu, M.C. Abad, P.J. Connolly, M.P. Neeper, G.T. Struble, B.A. Springer, S.L. Emanuel, N. Pandey, R.H. Gruninger, M. Adams, S. Moreno-Mazza, A.R. Fuentes-Pesquera, S.A. Middleton, Bioorg. Med. Chem. Lett. 18, 4615 (2008)
Acknowledgements
One of the authors (PPW) thanks the Department of Science and Technology, New Delhi, for INSPIRE Fellowship (No. DST/INSPIRE Fellowship/2013/197). We gratefully thank ACTREC, Mumbai, India, for providing anticancer screening of compounds.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Warekar, P.P., Patil, K.T., Patil, P.T. et al. Design and synthesis of some new piritrexim analogs as potential anticancer agents. Res Chem Intermed 44, 749–767 (2018). https://doi.org/10.1007/s11164-017-3132-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11164-017-3132-z